LONDON — Back in the 1950s, Battersea Power Station, a towering brick structure on the south bank of the Thames, supplied a fifth of London’s electricity, an economic engine that even powered Buckingham Palace.
The coal-fired plant was decommissioned decades ago. But on Thursday evening, in an art deco, gold-and-glass control room in the recently retrofitted power station — now a multi-use development complete with apartments and a cinema — the U.K. government and the biotech company Moderna celebrated the launch of a 10-year partnership, one they touted as a major economic and health security advance.
If the symbolism wasn’t explicit enough, speakers at the event couldn’t help but make it so.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect